1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Medical Research Institution 1.3.3 Hospital and Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2018-2029) 2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Region 2.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Size by Region (2018-2023) 2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2024-2029) 2.3 Synthetic Lethality-based Drugs and Targets Market Dynamics 2.3.1 Synthetic Lethality-based Drugs and Targets Industry Trends 2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers 2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges 2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue 3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2018-2023) 3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2018-2023) 3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue 3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio 3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2022 3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served 3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service 3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type 4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2018-2023) 4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2024-2029) 5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application 5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2018-2023) 5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2018-2029) 6.2 North America Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) 6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2018-2029) 7.2 Europe Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) 7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2018-2029) 8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023) 8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2018-2029) 9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) 9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2018-2029) 10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) 10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Detail 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction 11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.1.5 AbbVie Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Detail 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction 11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.2.5 AstraZeneca Recent Development 11.3 BeiGene 11.3.1 BeiGene Company Detail 11.3.2 BeiGene Business Overview 11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction 11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.3.5 BeiGene Recent Development 11.4 Clovis Oncology 11.4.1 Clovis Oncology Company Detail 11.4.2 Clovis Oncology Business Overview 11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction 11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.4.5 Clovis Oncology Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Detail 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction 11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.5.5 GlaxoSmithKline Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Detail 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction 11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.6.5 Pfizer Recent Development 11.7 AtlasMedx 11.7.1 AtlasMedx Company Detail 11.7.2 AtlasMedx Business Overview 11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction 11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.7.5 AtlasMedx Recent Development 11.8 Chordia Therapeutics 11.8.1 Chordia Therapeutics Company Detail 11.8.2 Chordia Therapeutics Business Overview 11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.8.5 Chordia Therapeutics Recent Development 11.9 IDEAYA Biosciences 11.9.1 IDEAYA Biosciences Company Detail 11.9.2 IDEAYA Biosciences Business Overview 11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction 11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.9.5 IDEAYA Biosciences Recent Development 11.10 Mission Therapeutics 11.10.1 Mission Therapeutics Company Detail 11.10.2 Mission Therapeutics Business Overview 11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.10.5 Mission Therapeutics Recent Development 11.11 Repare Therapeutics 11.11.1 Repare Therapeutics Company Detail 11.11.2 Repare Therapeutics Business Overview 11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction 11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.11.5 Repare Therapeutics Recent Development 11.12 Sierra Oncology 11.12.1 Sierra Oncology Company Detail 11.12.2 Sierra Oncology Business Overview 11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction 11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.12.5 Sierra Oncology Recent Development 11.13 SyntheX Labs 11.13.1 SyntheX Labs Company Detail 11.13.2 SyntheX Labs Business Overview 11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction 11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) 11.13.5 SyntheX Labs Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2018-2023) Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2024-2029) Table 10. Synthetic Lethality-based Drugs and Targets Market Trends Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2018-2023) Table 16. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2022) Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2018-2023) Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2024-2029) Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2018-2023) Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2024-2029) Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2024-2029) & (US$ Million) Table 46. AbbVie Company Detail Table 47. AbbVie Business Overview Table 48. AbbVie Synthetic Lethality-based Drugs and Targets Product Table 49. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 50. AbbVie Recent Development Table 51. AstraZeneca Company Detail Table 52. AstraZeneca Business Overview Table 53. AstraZeneca Synthetic Lethality-based Drugs and Targets Product Table 54. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 55. AstraZeneca Recent Development Table 56. BeiGene Company Detail Table 57. BeiGene Business Overview Table 58. BeiGene Synthetic Lethality-based Drugs and Targets Product Table 59. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 60. BeiGene Recent Development Table 61. Clovis Oncology Company Detail Table 62. Clovis Oncology Business Overview Table 63. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product Table 64. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 65. Clovis Oncology Recent Development Table 66. GlaxoSmithKline Company Detail Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product Table 69. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 70. GlaxoSmithKline Recent Development Table 71. Pfizer Company Detail Table 72. Pfizer Business Overview Table 73. Pfizer Synthetic Lethality-based Drugs and Targets Product Table 74. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 75. Pfizer Recent Development Table 76. AtlasMedx Company Detail Table 77. AtlasMedx Business Overview Table 78. AtlasMedx Synthetic Lethality-based Drugs and Targets Product Table 79. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 80. AtlasMedx Recent Development Table 81. Chordia Therapeutics Company Detail Table 82. Chordia Therapeutics Business Overview Table 83. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product Table 84. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 85. Chordia Therapeutics Recent Development Table 86. IDEAYA Biosciences Company Detail Table 87. IDEAYA Biosciences Business Overview Table 88. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product Table 89. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 90. IDEAYA Biosciences Recent Development Table 91. Mission Therapeutics Company Detail Table 92. Mission Therapeutics Business Overview Table 93. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product Table 94. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 95. Mission Therapeutics Recent Development Table 96. Repare Therapeutics Company Detail Table 97. Repare Therapeutics Business Overview Table 98. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product Table 99. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 100. Repare Therapeutics Recent Development Table 101. Sierra Oncology Company Detail Table 102. Sierra Oncology Business Overview Table 103. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product Table 104. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 105. Sierra Oncology Recent Development Table 106. SyntheX Labs Company Detail Table 107. SyntheX Labs Business Overview Table 108. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product Table 109. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2018-2023) & (US$ Million) Table 110. SyntheX Labs Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2022 VS 2029 Figure 3. Monotherapy Features Figure 4. Combination Therapy Features Figure 5. Global Synthetic Lethality-based Drugs and Targets Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2022 VS 2029 Figure 7. Medical Research Institution Case Studies Figure 8. Hospital and Clinic Case Studies Figure 9. Other Case Studies Figure 10. Synthetic Lethality-based Drugs and Targets Report Years Considered Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Region: 2022 VS 2029 Figure 14. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2022 Figure 15. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2022) Figure 16. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2022 Figure 17. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029) Figure 19. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029) Figure 23. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Region (2018-2029) Figure 31. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029) Figure 39. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Country (2018-2029) Figure 43. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 46. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 47. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 48. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 49. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 50. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 51. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 52. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 53. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 54. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 55. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 56. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 57. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2018-2023) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

AbbVie AstraZeneca BeiGene Clovis Oncology GlaxoSmithKline Pfizer AtlasMedx Chordia Therapeutics IDEAYA Biosciences Mission Therapeutics Repare Therapeutics Sierra Oncology SyntheX Labs